MyFinsight
Home
Blog
About
Contact
Download
Download image
Royalty
$867,840K
Product
$376,444K
Collaborative Agreements
$152,327K
Total revenues
$1,396,611K
Operating income
$469,006K
Investment and other
income, net
$21,472K
Total operating
expenses
$927,605K
Income before income
tax expense
$466,875K
Interest expense
$18,126K
Inducement expense related
to convertible...
$5,477K
Acquired in-process
research and development...
$284,887K
Cost of sales
$228,774K
Selling, general and
administrative
$207,092K
Research and development
$81,490K
Amortization of intangibles
$76,662K
Impairment of intangible
asset
$48,700K
Net income
$316,889K
Income tax expense
$149,986K
Back
Back
Income Statement
source: myfinsight.com
HALOZYME THERAPEUTICS, INC. (HALO)
HALOZYME THERAPEUTICS, INC. (HALO)